Cape Investment Advisory’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.6K Buy
+257
New +$22.5K 0.01% 671
2026
Q1
Sell
-249
Closed -$19.7K 382
2025
Q4
$19.7K Buy
249
+45
+22% +$3.53K 0.01% 614
2025
Q3
$16.3K Sell
204
-41
-17% -$3.5K 0.02% 341
2025
Q2
$22.3K Buy
245
+3
+1% +$274 0.01% 489
2025
Q1
$22.7K Sell
242
-3
-1% -$269 0.01% 456
2024
Q4
$22.3K Buy
245
+203
+483% +$19.4K 0.01% 462
2024
Q3
$4.36K Hold
42
﹤0.01% 734
2024
Q2
$4.08K Hold
42
﹤0.01% 703
2024
Q1
$3.78K Hold
42
﹤0.01% 693
2023
Q4
$3.35K Hold
42
﹤0.01% 843
2023
Q3
$2.99K Hold
42
﹤0.01% 751
2023
Q2
$3.24K Hold
42
﹤0.01% 727
2023
Q1
$3.16K Buy
+42
New +$3.12K ﹤0.01% 760

Other funds holding CL

Cape Investment Advisory's CL Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in Colgate-Palmolive (CL) in Q2 2026: 257 shares worth $23.6K. The stake represents 0.01% of the portfolio and ranks #671 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in CL as recently as Q4 2025.

Cape Investment Advisory first reported a position in CL in Q1 2023 and has held it in 13 quarters since. 668 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Cape Investment Advisory held 257 shares of Colgate-Palmolive worth $23.6K as of Q2 2026.
  • Colgate-Palmolive was a new Cape Investment Advisory position in Q2 2026.
  • Colgate-Palmolive made up 0.01% of Cape Investment Advisory's portfolio in Q2 2026, its #671 holding.
  • Cape Investment Advisory first reported a position in Colgate-Palmolive in Q1 2023 and has held it in 13 quarters since.
  • 668 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.